T

Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119

Watchlist Manager
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
Watchlist
Price: 18.4 CNY -4.66% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Tianjin Ringpu Bio-Technology Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Tianjin Ringpu Bio-Technology Co Ltd

Current Assets 3.1B
Cash & Short-Term Investments 1.5B
Receivables 1.1B
Other Current Assets 440.5m
Non-Current Assets 4.1B
Long-Term Investments 1.1B
PP&E 1.9B
Intangibles 993.3m
Other Non-Current Assets 53.2m
Current Liabilities 1.7B
Accounts Payable 352.8m
Accrued Liabilities 46.7m
Short-Term Debt 841m
Other Current Liabilities 463.1m
Non-Current Liabilities 1B
Long-Term Debt 429.2m
Other Non-Current Liabilities 599.3m

Balance Sheet
Tianjin Ringpu Bio-Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
414
268
295
398
288
289
264
1 280
377
322
Cash
0
0
0
0
0
0
0
1 280
377
322
Cash Equivalents
413
268
295
398
288
289
264
0
0
0
Short-Term Investments
0
0
0
0
0
385
400
699
1 517
1 483
Total Receivables
322
347
354
385
456
410
513
655
803
1 019
Accounts Receivables
271
296
308
344
381
348
443
573
743
943
Other Receivables
51
51
46
41
75
62
70
82
60
76
Inventory
143
182
219
237
258
264
364
360
367
390
Other Current Assets
29
104
306
299
359
185
64
67
30
50
Total Current Assets
907
901
1 173
1 318
1 361
1 532
1 605
3 062
3 093
3 263
PP&E Net
803
920
936
929
954
1 033
1 116
1 300
1 600
1 654
PP&E Gross
803
920
936
929
954
1 033
1 116
1 300
1 600
1 654
Accumulated Depreciation
138
193
247
306
372
418
449
460
537
600
Intangible Assets
233
311
321
331
330
350
367
385
401
419
Goodwill
1
70
70
68
68
68
68
68
68
68
Long-Term Investments
32
124
208
249
248
509
677
802
927
1 118
Other Long-Term Assets
14
22
25
29
38
71
67
74
17
74
Other Assets
1
70
70
68
68
68
68
68
68
68
Total Assets
1 989
N/A
2 349
+18%
2 733
+16%
2 924
+7%
2 998
+3%
3 563
+19%
3 899
+9%
5 691
+46%
6 106
+7%
6 596
+8%
Liabilities
Accounts Payable
78
143
142
138
144
157
188
221
329
372
Accrued Liabilities
19
27
28
30
33
58
79
84
103
91
Short-Term Debt
35
157
271
448
454
703
487
662
744
739
Current Portion of Long-Term Debt
0
0
0
0
3
37
7
47
19
22
Other Current Liabilities
57
169
77
42
32
92
116
109
114
120
Total Current Liabilities
189
495
518
657
666
1 046
877
1 124
1 310
1 345
Long-Term Debt
0
0
15
9
0
55
154
101
192
316
Deferred Income Tax
0
6
9
10
16
45
70
89
52
77
Minority Interest
112
161
202
224
244
235
282
291
280
309
Other Liabilities
70
78
85
72
62
60
61
54
51
54
Total Liabilities
371
N/A
741
+100%
830
+12%
972
+17%
988
+2%
1 441
+46%
1 444
+0%
1 658
+15%
1 885
+14%
2 100
+11%
Equity
Common Stock
389
389
405
405
405
405
405
468
468
466
Retained Earnings
409
481
555
599
658
858
1 156
1 409
1 592
1 905
Additional Paid In Capital
820
738
944
948
948
943
963
2 223
2 203
2 194
Treasury Stock
0
0
0
0
0
83
68
67
41
69
Total Equity
1 618
N/A
1 608
-1%
1 904
+18%
1 952
+3%
2 010
+3%
2 122
+6%
2 456
+16%
4 033
+64%
4 222
+5%
4 496
+7%
Total Liabilities & Equity
1 989
N/A
2 349
+18%
2 733
+16%
2 924
+7%
2 998
+3%
3 563
+19%
3 899
+9%
5 691
+46%
6 106
+7%
6 596
+8%
Shares Outstanding
Common Shares Outstanding
389
389
405
405
405
395
397
461
461
459

See Also

Discover More